Literature DB >> 16557932

Effect of Purified Rabbit Anti-Salmonella typhimurium Antibodies on the Fate of Intravenously Injected Bacteria.

M L Schulkind1, P Rabins.   

Abstract

Purified IgM and IgG antibodies to Salmonella typhimurium "O" antigen were prepared from rabbit serum collected "early" (6 to 8 days) and "late" (30 to 32 days) during the course of the immune response. The effect which these passively administered antibodies had upon the reticuloendothelial organ sequestration of intravenously injected (125)I-labeled heat-killed S. typhimurium in nonimmune rabbits was studied. In the absence of specific antibody, the spleen (per gram) sequestered more organisms than did the liver, kidneys, and lungs. In the presence of "early" antibody to S. typhimurium, sequestration of organisms in the spleen was two to three times greater than sequestration in the spleen of animals that had received "late" antibody to S. typhimurium, heterologous antibody or no antibody. Although "late" antibody did not increase sequestration of organisms in the spleen, it did result in a per gram liver sequestration of bacteria which was two times greater than that observed in animals that had received "early" antibodies to S. typhimurium, heterologous antibody or no antibody. The presence of passively administered antibody had no detectable effect upon the sequestration of bacteria in the kidneys and the lungs. Thus, it would seem that antibodies isolated early in the immune response increase the efficiency of splenic sequestration of blood-borne particulate material, whereas "late" antibody favors sequestration in the liver.

Entities:  

Year:  1971        PMID: 16557932      PMCID: PMC416121          DOI: 10.1128/iai.3.1.154-158.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  CHARACTERIZATION OF A HUMAN MACROGLOBULIN. I. THE MOLECULAR WEIGHT OF ITS SUBUNIT.

Authors:  F MILLER; H METZGER
Journal:  J Biol Chem       Date:  1965-08       Impact factor: 5.157

2.  Artificial radioactive antigens. III. S35-Sulfanil-azo-sheep red cell stromata; preparation and gross distribution in normal rabbits and mice.

Authors:  J S INGRAHAM
Journal:  J Infect Dis       Date:  1955 Mar-Apr       Impact factor: 5.226

3.  Isolation of antibodies to antigens of low molecular weight.

Authors:  D GIVOL; S FUCHS; M SELA
Journal:  Biochim Biophys Acta       Date:  1962-09-10

4.  Fractionation of human-serum proteins by gel filtration.

Authors:  P FLODIN; J KILLANDER
Journal:  Biochim Biophys Acta       Date:  1962-10-08

5.  Chromatographic studies of anomalous gamma-, beta2a-, and macroblobulins and normal gamma-globulins in myeloma and macroglobulinemic sera.

Authors:  J L FAHEY
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

6.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

7.  Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver.

Authors:  M L Schulkind; E F Ellis; R T Smith
Journal:  Pediatr Res       Date:  1967-05       Impact factor: 3.756

8.  Bacteremia: a consideration of some experimental and clinical aspects.

Authors:  I L BENNETT; P B BEESON
Journal:  Yale J Biol Med       Date:  1954-02

9.  A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system.

Authors:  B BENACERRAF; M M SEBESTYEN; S SCHLOSSMAN
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

10.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  1 in total

1.  Passive protection of mice against intraperitoneally injected Vibrio cholerae by G and M antibody.

Authors:  R M Pike; C H Chandler
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.